Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Linking Individuals Needing Care for Substance Use Disorders to Peer Coaches & Across INcarceration Settings (LINCS UP & IN)

13 augustus 2026 bijgewerkt door: Joseph Carpenter, Emory University

The goal of this study is to learn whether a virtual peer recovery coach (PRC) intervention can improve engagement in addiction treatment among incarcerated adults with substance use disorders.

The main questions it aims to answer are:

  • Does the PRC intervention increase engagement with at least one recovery resource at 30 and 90 days?
  • Does it improve secondary outcomes such as substance use, recovery capital, overdose events, and recidivism?

Researchers will compare Treatment-as-Usual with the PRC telehealth intervention to see if PRC support improves engagement in addiction care.

Participants will:

  • Complete baseline and follow-up assessments
  • Receive either Treatment-as-Usual or a virtual PRC session focused on motivational interviewing and linkage to recovery resources

Studie Overzicht

Gedetailleerde beschrijving

This study evaluates a virtual peer recovery coach (PRC) intervention designed to support adults with substance use disorders during incarceration and the transition back to the community. The trial is conducted across multiple jail facilities in Metro Atlanta, where individuals experience high rates of substance use disorders and limited access to treatment services. Peer recovery coaches-individuals with lived experience who are trained in motivational interviewing and linkage to care-have demonstrated benefit in healthcare settings, but their effectiveness within jail environments has not been rigorously tested.

The intervention adapts an existing virtual PRC model for use in jail settings. PRCs meet with participants through a secure telehealth platform and provide individualized support focused on motivation, readiness for change, and connection to recovery resources. The model is designed to be scalable, flexible, and responsive to the needs of individuals with diverse substance use profiles, including those for whom no FDA-approved medications exist.

The study uses a phased implementation approach in which participating jail sites transition from usual care to the PRC intervention over time. This structure allows the program to be integrated into each facility's workflow while enabling evaluation of the intervention's impact. Participants are followed for one year to assess engagement with recovery resources and other indicators of health, stability, and community reintegration.

The findings will inform whether virtual PRC services can be effectively delivered in jail settings and whether they improve connection to treatment and recovery supports during a period of heightened vulnerability. Results may guide future implementation of peer-based models in correctional systems and other high-risk environments.

Studietype

Ingrijpend

Inschrijving (Geschat)

550

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Contact Back-up

Studie Locaties

    • Georgia
      • Atlanta, Georgia, Verenigde Staten, 30303
        • Werving
        • Atlanta City Detention Center
      • Atlanta, Georgia, Verenigde Staten, 30318
        • Werving
        • Fulton County Jail
      • Decatur, Georgia, Verenigde Staten, 30032
        • Werving
        • Dekalb County Jail

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Ja

Beschrijving

Inclusion Criteria:

  • Incarcerated at participating jail
  • Able to speak and understand English
  • Score of 3 or greater - "moderate level", "substantial level", or "severe level" of problems related to drug abuse - on DAST-10.
  • Willing to follow study procedures and complete research follow-up calls
  • Have at least two reliable contact numbers, e.g. participant and one or more relatives or close friends

Exclusion Criteria:

  • Cognitive impairment (inability to comprehend the informed consent document as assessed by study staff during enrollment)
  • Prior participation in the study
  • Awaiting transfer to prison or jail outside the state of Georgia

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ondersteunende zorg
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: PRC group
Participants meet virtually with a trained peer recovery coach using a secure telehealth platform. PRCs use motivational interviewing, assess readiness to change, and provide individualized linkage to recovery resources. Support may include connection to medications for opioid use disorder, residential treatment, detoxification centers, harm reduction services, mutual support groups, sober living, or recovery community organizations. PRCs may also conduct post-release check-ins to support ongoing engagement.
A telehealth session with a peer recovery coach who provides motivational interviewing and tailored linkage to addiction treatment and recovery resources.
Actieve vergelijker: Standard of Care
Participants receive the jail's standard approach to substance use support. This includes a review of available community treatment and recovery resources consistent with existing facility practices. No peer recovery coach is involved, and no additional study-driven services are provided.
Participants are provided information about community-based addiction treatment and recovery resources as part of routine jail processes.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Engagement With at Least One Recovery Resource
Tijdsspanne: 30 days and 90 days after enrollment

Engagement with at least one recovery resource, defined as:

  • Formal addiction treatment (visit with a physician, psychologist, or licensed substance use counselor; or ≥1 night in detoxification or residential treatment), or
  • Recovery Community Organization (RCO) participation (contact, intake, and participation in ≥1 evidence-based recovery activity), or
  • Harm reduction organization engagement. Engagement may occur during incarceration or in the community after release.
30 days and 90 days after enrollment

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Days Receiving Medications for Substance Use Disorders
Tijdsspanne: Baseline to 30 days, 90 days, 180 days, and 1 year
Number of days participants receive medications for opioid use disorder (MOUD), stimulant use disorder, or alcohol use disorder.
Baseline to 30 days, 90 days, 180 days, and 1 year
Recidivism and Justice Involvement
Tijdsspanne: Baseline to 1 year
New arrests, bookings, or jail stays documented through participant report or administrative data.
Baseline to 1 year
Healthcare Utilization
Tijdsspanne: Baseline to 1 year
Emergency department visits, hospitalizations, and other acute care encounters.
Baseline to 1 year
Recovery Capital (BARC-10)
Tijdsspanne: Baseline, 30, 90, 180 days, and 1 year

Brief Assessment of Recovery Capital (BARC-10) A 10-item validated scale that measures a person's internal and external resources that support recovery from substance use. Items assess domains such as social support, coping skills, housing stability, and personal motivation.

  • Scores range from 10 to 60.
  • Higher scores indicate greater recovery capital and stronger readiness to sustain recovery.
Baseline, 30, 90, 180 days, and 1 year
Number of Peer Recovery Coach Contacts
Tijdsspanne: Baseline to 30 days, 90 days, 180 days, and 1 year
Number of PRC interactions among participants assigned to the intervention arm.
Baseline to 30 days, 90 days, 180 days, and 1 year
Self-Reported Substance Use (TLFB)
Tijdsspanne: Baseline, 30, 90, 180 days, and 1 year
Days of substance use in the past 30 days using the Timeline Follow-Back method. A structured calendar-based interview used to measure self-reported substance use over the past 30 days. Participants recall days of use using memory anchors (events, routines).
Baseline, 30, 90, 180 days, and 1 year
Fatal Overdose Events
Tijdsspanne: Baseline through 1 year
Overdose events identified through participant report, medical records, or community partner data.
Baseline through 1 year
Nonfatal Overdose Events
Tijdsspanne: Baseline through 1 year
Overdose events identified through participant report, medical records, or community partner data.
Baseline through 1 year
Housing status
Tijdsspanne: Baseline, 30, 90, 180 days, and 1 year
Current housing status (stable, unstable, homeless)
Baseline, 30, 90, 180 days, and 1 year
Employment status
Tijdsspanne: Baseline, 30, 90, 180 days, and 1 year
Employment status (full-time, part-time, unemployed)
Baseline, 30, 90, 180 days, and 1 year
Social connections and Isolation: PROMIS scale
Tijdsspanne: Baseline, 30, 90, 180 days, and 1 year

A validated set of items assessing perceived social support, loneliness, and connectedness.

  • Generates T-scores standardized to the U.S. population (mean = 50, SD = 10).
  • Higher scores on Social Support = more support.
  • Used to evaluate social determinants of recovery.
Baseline, 30, 90, 180 days, and 1 year
All-Cause Mortality
Tijdsspanne: Baseline through 1 year
Death from any cause, confirmed through vital records or the National Death Index.
Baseline through 1 year

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Joseph Carpenter, MD, Emory University

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

1 september 2026

Primaire voltooiing (Geschat)

1 maart 2030

Studie voltooiing (Geschat)

1 maart 2030

Studieregistratiedata

Eerst ingediend

22 april 2026

Eerst ingediend dat voldeed aan de QC-criteria

29 april 2026

Eerst geplaatst (Werkelijk)

4 mei 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

17 augustus 2026

Laatste update ingediend die voldeed aan QC-criteria

13 augustus 2026

Laatst geverifieerd

1 augustus 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • 2025P012936
  • 1R01DA064519-01 (Subsidie/contract van de Amerikaanse NIH)

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren